These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11850224)

  • 1. Regulation of aromatase by nuclear receptors.
    Yanase T; Mu YM; Nishi Y; Goto K; Nomura M; Okabe T; Takayanagi R; Nawata H
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):187-92. PubMed ID: 11850224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nuclear receptor system constituted by RAR and RXR induces aromatase activity in MCF-7 human breast cancer cells.
    Mu YM; Yanase T; Nishi Y; Hirase N; Goto K; Takayanagi R; Nawata H
    Mol Cell Endocrinol; 2000 Aug; 166(2):137-45. PubMed ID: 10996432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment with specific ligands for PPARgamma:RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells.
    Mu YM; Yanase T; Nishi Y; Takayanagi R; Goto K; Nawata H
    Mol Cell Endocrinol; 2001 Jul; 181(1-2):239-48. PubMed ID: 11476957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells.
    Mu YM; Yanase T; Nishi Y; Waseda N; Oda T; Tanaka A; Takayanagi R; Nawata H
    Biochem Biophys Res Commun; 2000 May; 271(3):710-3. PubMed ID: 10814527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle.
    Cha BS; Ciaraldi TP; Carter L; Nikoulina SE; Mudaliar S; Mukherjee R; Paterniti JR; Henry RR
    Diabetologia; 2001 Apr; 44(4):444-52. PubMed ID: 11357475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose.
    Rubin GL; Duong JH; Clyne CD; Speed CJ; Murata Y; Gong C; Simpson ER
    Endocrinology; 2002 Aug; 143(8):2863-71. PubMed ID: 12130549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of peroxisome proliferator-activated receptor-gamma and retinoid X receptor inhibits aromatase transcription via nuclear factor-kappaB.
    Fan W; Yanase T; Morinaga H; Mu YM; Nomura M; Okabe T; Goto K; Harada N; Nawata H
    Endocrinology; 2005 Jan; 146(1):85-92. PubMed ID: 15459115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a region upstream of exon I.1 of the human CYP19 (aromatase) gene that mediates regulation by retinoids in human choriocarcinoma cells.
    Sun T; Zhao Y; Mangelsdorf DJ; Simpson ER
    Endocrinology; 1998 Apr; 139(4):1684-91. PubMed ID: 9528950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
    Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
    Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
    Rubin GL; Zhao Y; Kalus AM; Simpson ER
    Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
    Mehta RG; Williamson E; Patel MK; Koeffler HP
    J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo.
    Cesario RM; Klausing K; Razzaghi H; Crombie D; Rungta D; Heyman RA; Lala DS
    Mol Endocrinol; 2001 Aug; 15(8):1360-9. PubMed ID: 11463859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
    Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
    Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoid X receptor (RXR) ligands activate the human 25-hydroxyvitamin D3-24-hydroxylase promoter via RXR heterodimer binding to two vitamin D-responsive elements and elicit additive effects with 1,25-dihydroxyvitamin D3.
    Zou A; Elgort MG; Allegretto EA
    J Biol Chem; 1997 Jul; 272(30):19027-34. PubMed ID: 9228086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
    Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor.
    Vu-Dac N; Schoonjans K; Kosykh V; Dallongeville J; Heyman RA; Staels B; Auwerx J
    Mol Cell Biol; 1996 Jul; 16(7):3350-60. PubMed ID: 8668150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinedione induces apoptosis and monocytic differentiation in the promyelocytic leukemia cell line HL60.
    Hirase N; Yanase T; Mu Y; Muta K; Umemura T; Takayanagi R; Nawata H
    Oncology; 1999 Oct; 57 Suppl 2():17-26. PubMed ID: 10545799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of a fibroblast growth factor-binding protein by receptor-selective analogs of retinoic acid.
    Boyle BJ; Harris VK; Liaudet-Coopman ED; Riegel AT; Wellstein A
    Biochem Pharmacol; 2000 Dec; 60(11):1677-84. PubMed ID: 11077050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
    Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
    Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.